Curewell Pharmakon Private Limited

Curewell Pharmakon Private Limited - trading in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
CIN U24231JK1989PTC001099 Incorporated 31 March 1989 ROC Jammu HQ Jammu, Jammu And Kashmir, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹2.76 Cr
▼ 2% YoY
Net profit · FY 2025
₹1.27 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹4.66 Lakh
EBITDA margin 1.7%
Authorised capital
₹6 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹54.21 Lakh
Secured borrowings
Company age
37 yrs
Est. 1989
Employees · EPFO
2
Provident fund records

About Curewell Pharmakon Private Limited

Data last updated:

Curewell Pharmakon Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 31 March 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24231JK1989PTC001099. Its GSTIN is 01AAACC6571D1Z8 (Jammu and Kashmir).

The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Anu Gupta and Sumati Mahajan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 145 Raghunath Pura, Jammu, Jammu and Kashmir, India – 180001.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.76 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.27 Lakh (net margin 0.5%) and EBITDA of ₹4.66 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 17% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹54.21 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231JK1989PTC001099
Registration Number 001099
Incorporation Date 31 March 1989
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Curewell Pharmakon Private Limited's registered office is in Jammu, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H.No. 145 Raghunath Pura, Jammu, Jammu and Kashmir, India – 180001
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Curewell Pharmakon Private Limited, buy the company report.

Comprehensive company report
Curewell Pharmakon Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Curewell Pharmakon is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Curewell Pharmakon Private Limited, buy the company report.

Financials of Curewell Pharmakon Private Limited

FY 2025 filings available

Curewell Pharmakon Private Limited reported revenue of ₹2.76 Cr (down 2% YoY) for FY 2025.

Revenue · FY 2025
₹2.76 Cr ▼ 2%
Net profit · FY 2025
₹1.27 Lakh margin 0.5%
EBITDA · FY 2025
₹4.66 Lakh margin 1.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 14%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 35%
5 years · compounded
▲ 22%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.66 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.27 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.7%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Curewell Pharmakon Private Limited, buy the company report.

Board of directors of Curewell Pharmakon Private Limited

Curewell Pharmakon has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anu GuptaDirector17 Nov 20178 Years 11 MonthsCurrent
Sumati MahajanDirector31 Dec 20205 Years 10 MonthsCurrent

Peer comparison

Curewell Pharmakon Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dalma Infracon Private Limited₹2.76 Cr (FY 2025)39.0%Jamshedpur, Jharkhand, India
Webtreasure Eservices Private Limited₹2.76 Cr (FY 2024)Gurgaon, Haryana, India
Mark Enclave Private Limited₹2.76 Cr (FY 2025)-71.0%Kolkata, West Bengal, India
Kvson Endeavour Private Limited₹2.76 Cr (FY 2025)9.0%Siliguri, West Bengal, India
Damar India Private Limited₹2.76 Cr (FY 2025)-9.0%Begusarai, Bihar, India
Curewell Pharmakon Private Limitedthis company₹2.76 Cr (FY 2025)₹1.27 Lakh0.5%-2.0%2Jammu, Jammu And Kashmir, India
M. K. Aruna Leasing & Properties Limited₹2.76 Cr (FY 2025)96.0%Delhi, India
Soltex Trade Private Limited₹2.76 Cr (FY 2025)56.0%Delhi, India
Zoonis India Private Limited₹2.76 Cr (FY 2025)-2.0%Rani Khera, Delhi, India
Genisys Global IT Solutions Private Limited₹2.76 Cr (FY 2025)-8.0%New Delhi, Delhi, India
Welfeed Remedies Private Limited₹2.76 Cr (FY 2025)2.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Curewell Pharmakon Private Limited, buy the company report.

Auditor

Curewell Pharmakon Private Limited is audited by WIG SINBAD & CO CHARTERED ACCOUNTANTS for the financial year 2017.

Auditor firmFinancial yearFirm registration number
WIG SINBAD & CO CHARTERED ACCOUNTANTSFY 2017010893N

Shareholding

The shareholding of Curewell Pharmakon Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Curewell Pharmakon Private Limited, buy the company report.

Charges & borrowings

Open charges
₹54.21 Lakh
Satisfied charges
None
Breakdown by lending institutions
Central Bank of India₹0.28 Cr
The Jammu and Kashmir Bank Limited₹0.21 Cr
Hdfc Bank Limited₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Jun 2023100764049Hdfc Bank Limited₹5.21 LakhOpen
29 May 2023100747277The Jammu and Kashmir Bank Limited₹21 LakhOpen
24 Dec 200290323860Central Bank of India₹22 LakhOpen
28 Jan 199390323644Central Bank of India₹2 LakhOpen
21 Jul 199290324022Central Bank of India₹4 LakhOpen

To see the full charge records of Curewell Pharmakon Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Curewell Pharmakon Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Curewell Pharmakon Private Limited has a workforce of 2 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
2
Active EPFO establishments
1
Employee growth
100%

GST

Curewell Pharmakon has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
01AAACC6571D1Z8Jammu and KashmirActive08 Jul 2017

To see the full GST registrations and return filing status of Curewell Pharmakon Private Limited, buy the company report.

Recent activity

Curewell Pharmakon Private Limited has 9 board changes on record since 2017: 2 appointments and 7 cessations. The latest: Sumati Mahajan ceased to be Additional Director on 30 Nov 2021.

AGM
Curewell Pharmakon Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with The Jammu And Kashmir Bank Limited of Rs. 21.00 Lakh registered on 29 May 2023 with Charge ID 100747277 was modified on 09 May 2025.
Filing
Curewell Pharmakon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.21 Lakh with Charge ID 100764049 was registered on 29 Jun 2023.
Charges
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 21.00 Lakh with Charge ID 100747277 was registered on 29 May 2023.
Ceased
Sumati Mahajan ceased to be Additional Director.
Ceased
Narinder Sharma ceased to be Director.
Appointed
Sumati Mahajan was appointed as Director.
Ceased
Ravi Kant Mahajan ceased to be Director.
Ceased
Anu Gupta ceased to be Additional Director.
Ceased
Rajiv Kapahi ceased to be Additional Director.
Appointed
Anu Gupta was appointed as Director.

8 earlier events are in the company report.

Frequently asked questions

Curewell Pharmakon is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in other wholesale, within the trading industry. It was incorporated on 31 March 1989 (37+ years old) and is registered under CIN U24231JK1989PTC001099.

Curewell Pharmakon has 2 current directors:

The latest financial statements of Curewell Pharmakon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Curewell Pharmakon is 01AAACC6571D1Z8, registered in Jammu and Kashmir.

The CIN (Corporate Identification Number) of Curewell Pharmakon is U24231JK1989PTC001099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curewell Pharmakon was incorporated on 31 March 1989, making it 37+ years old. It is registered with the Registrar of Companies, Jammu.

The peers of Curewell Pharmakon by revenue are Dalma Infracon Private Limited, Webtreasure Eservices Private Limited, Mark Enclave Private Limited, Kvson Endeavour Private Limited, Damar India Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Sumati Mahajan ceased to be Additional Director on 30 Nov 2021. Narinder Sharma ceased to be Director on 31 Dec 2020. Sumati Mahajan was appointed as Director on 31 Dec 2020. Curewell Pharmakon has 9 board changes on record in total.

The registered office of Curewell Pharmakon is at H.No. 145 Raghunath Pura, Jammu, Jammu and Kashmir, India – 180001.

Curewell Pharmakon operates in the trading industry, in the other wholesale segment.

Curewell Pharmakon has open charges of ₹54.21 Lakh and no satisfied charges on record as per latest MCA filings.